Difficulty conceiving is not always related to female fertility. Male reproductive health plays an equally important role in achieving pregnancy, and identifying potential male fertility concerns early can help couples make informed treatment decisions.
At Life Fertility Centre, South Mumbai, Dr. Katha Desai provides comprehensive fertility evaluation and individualised treatment planning for couples experiencing difficulty conceiving. Male fertility assessments may include semen analysis, hormonal investigations, sperm DNA fragmentation testing and evaluation for conditions affecting sperm production or transport.
Whether you are concerned about low sperm count, poor sperm motility, abnormal sperm morphology or azoospermia (absence of sperm in semen), understanding the underlying cause is the first step towards identifying appropriate treatment options.
Male infertility is a medical condition, not a reflection of masculinity, sexual performance or personal worth.
Male infertility refers to a man's reduced ability to contribute to achieving pregnancy because of problems involving sperm production, sperm function, sperm delivery or other reproductive factors.
Infertility is generally defined as the inability to achieve pregnancy after 12 months of regular, unprotected sexual intercourse. Earlier evaluation may be appropriate when there are known reproductive concerns, the female partner is aged 35 years or older, or other clinical factors are present.
Male fertility problems may occur even when a man has normal sexual desire, erections and ejaculation.
Some conditions are temporary or treatable, while others may require assisted reproductive techniques such as IVF with intracytoplasmic sperm injection (ICSI).
Male factors contribute to approximately 40–50% of couples experiencing infertility, either independently or alongside female reproductive factors.
This does not mean that 40–50% of men are infertile. Rather, male reproductive factors are involved in a substantial proportion of couples who experience difficulty conceiving.
Both partners should ideally undergo fertility evaluation at the same time.
A timely assessment may help:
A normal sexual life does not necessarily indicate normal sperm quality.
Male infertility may result from problems with sperm production, sperm movement, sperm structure, hormonal regulation or the reproductive tract.
Oligospermia refers to a sperm concentration below the laboratory's reference range.
A reduced sperm count may lower the probability of natural conception, although pregnancy can still occur in some cases.
Possible contributing factors include varicocele, hormonal disorders, genetic conditions, testicular injury, medication effects and certain lifestyle exposures.
Sperm motility describes the ability of sperm to move.
Progressively motile sperm are important because they must travel through the female reproductive tract to reach the egg.
Reduced motility may be associated with oxidative stress, varicocele, infections or other reproductive conditions.
Sperm morphology refers to the size and shape of sperm.
A high proportion of abnormally shaped sperm may be associated with reduced fertility potential. However, morphology alone does not reliably determine whether natural conception is possible.
Azoospermia occurs when no sperm are identified in the ejaculate after appropriate laboratory examination.
There are two major categories:
Obstructive azoospermia: Sperm production may be preserved, but a blockage prevents sperm from entering the ejaculate.
Non-obstructive azoospermia: Sperm production within the testes is severely impaired or absent.
Distinguishing between these conditions is essential because treatment options differ considerably.
A varicocele is an enlargement of veins within the scrotum.
It may affect testicular function, sperm production and sperm quality in some men.
Not every varicocele requires treatment. The decision depends on physical examination findings, semen parameters, fertility history and other clinical considerations.
Hormones such as follicle-stimulating hormone (FSH), luteinising hormone (LH) and testosterone regulate male reproductive function.
Conditions affecting the hypothalamus, pituitary gland or testes may interfere with sperm production.
Factors that may influence sperm health include:
Lifestyle factors may contribute to reduced sperm quality, but they do not explain every case of male infertility.
Many men with infertility have no obvious symptoms.
The most common indication is difficulty achieving pregnancy despite regular, unprotected intercourse.
Other possible signs include:
These symptoms do not necessarily indicate infertility, but they may justify medical evaluation.
At Life Fertility Centre, male fertility evaluation begins with a detailed review of reproductive history and appropriate investigations.
The purpose is not simply to identify an abnormal semen report, but to understand the possible underlying cause and its relevance to conception.
The fertility specialist reviews previous pregnancies, duration of infertility, sexual and reproductive history, medications, surgeries, lifestyle exposures and relevant medical conditions.
A physical examination by an appropriately trained clinician or andrologist may be recommended.
Semen analysis is usually the first laboratory investigation for male infertility.
It evaluates sperm concentration, motility, morphology, semen volume and other characteristics.
The WHO Laboratory Manual, Sixth Edition (2021), provides the following approximate lower fifth-percentile reference values from fertile populations:
| Semen parameter | WHO lower reference value |
|---|---|
| Semen volume | 1.4 mL |
| Sperm concentration | 16 million/mL |
| Total sperm number | 39 million per ejaculate |
| Total motility | 42% |
| Progressive motility | 30% |
| Normal morphology | 4% |
| Vitality | 54% |
These are reference limits, not strict boundaries between fertility and infertility.
A result below a reference value does not automatically mean a man cannot conceive. Likewise, results within the reference range do not guarantee fertility.
Semen parameters can fluctuate. When results are abnormal, repeat testing may be advised, generally after an appropriate interval.
Sperm DNA fragmentation testing assesses damage to genetic material within sperm.
Elevated DNA fragmentation has been associated with certain adverse reproductive outcomes, but its clinical interpretation depends on the testing method and patient circumstances.
DFI testing is not recommended routinely for every man during an initial infertility evaluation.
It may be considered in selected situations, such as recurrent pregnancy loss or particular unexplained fertility problems, after specialist assessment.
Hormonal testing may include:
These tests help identify possible hormonal causes of impaired sperm production.
A scrotal Doppler ultrasound may be recommended when clinical findings suggest a varicocele or another structural abnormality.
It is not routinely necessary for every patient undergoing an initial male infertility assessment.
In selected cases, particularly severe oligospermia or azoospermia, genetic investigations may be recommended.
These may include karyotyping, Y-chromosome microdeletion testing or CFTR-related testing when clinically indicated.
Treatment depends on the underlying diagnosis, reproductive goals, female partner's fertility status and previous treatment history.
Hormonal treatment may be appropriate for specific endocrine conditions. Lifestyle modifications can address smoking, weight, alcohol intake and harmful exposures. Antioxidant supplements have uncertain clinical benefits and should not be presented as a guaranteed way to improve fertility.
Varicocelectomy may be considered for selected infertile men with a palpable varicocele and abnormal semen parameters. The procedure aims to correct abnormal venous drainage and may improve semen quality in suitable cases.
ICSI involves injecting a single sperm directly into a mature egg in the IVF laboratory. It may be recommended for severe male-factor infertility, very low sperm count, significantly impaired motility or certain previous fertilisation problems.
IMSI uses high-magnification microscopy to select sperm based on detailed morphology before injection. It may be discussed in selected cases, but routine use has not been proven to improve live birth outcomes compared with conventional ICSI.
Men with azoospermia may require sperm retrieval procedures, depending on the cause. Options include PESA, TESA and micro-TESE, performed by appropriately trained specialists.
Surgical sperm retrieval techniques are used when sperm are absent from the ejaculate or cannot be obtained through conventional methods.
| Procedure | Full form | Typical clinical use |
|---|---|---|
| PESA | Percutaneous Epididymal Sperm Aspiration | Selected cases of obstructive azoospermia |
| TESA | Testicular Sperm Aspiration | Selected obstructive cases and other situations based on specialist assessment |
| Micro-TESE | Microsurgical Testicular Sperm Extraction | Selected cases of non-obstructive azoospermia |
PESA involves collecting sperm from the epididymis using a fine needle.
It may be appropriate when sperm production is preserved but sperm transport is obstructed.
TESA involves obtaining sperm directly from testicular tissue using needle aspiration.
The suitability of this procedure depends on the underlying diagnosis.
Micro-TESE uses an operating microscope to identify and retrieve small areas of testicular tissue that may contain sperm.
It is an important option for selected men with non-obstructive azoospermia.
However, sperm retrieval is not guaranteed, and some genetic findings may indicate a very low or absent likelihood of successful retrieval.
When sperm are successfully retrieved, they may be used for ICSI, depending on laboratory assessment and the couple's treatment plan.
Some men may experience improvements in semen parameters after addressing modifiable health and lifestyle factors.
Potential measures include maintaining a healthy weight, avoiding tobacco and anabolic steroids, limiting alcohol, improving sleep, exercising regularly and managing underlying medical conditions.
Because sperm development takes approximately two to three months, changes in semen parameters may not be apparent immediately.
However, lifestyle changes cannot reliably reverse all causes of male infertility, including significant genetic disorders or certain forms of testicular failure.
Medical evaluation is important before relying on supplements or home remedies.
Treatment outcomes depend on the cause and severity of infertility.
For some men, correcting a hormonal disorder or treating an appropriate varicocele may improve reproductive potential.
For others, assisted reproductive technologies such as IVF-ICSI may provide a pathway to pregnancy.
ICSI can help overcome certain fertilisation barriers, but it cannot correct every underlying sperm or embryo abnormality.
Important factors affecting treatment outcomes include:
No treatment can guarantee sperm retrieval, fertilisation, implantation or live birth. Individualised counselling is essential.
Male and female reproductive factors are evaluated together, helping avoid delays caused by investigating only one partner.
Investigations and treatment options are selected according to clinical findings rather than applying the same fertility package to every patient.
When appropriate, patients may be counselled about IVF, ICSI and specialist referral for surgical sperm retrieval.
Male infertility concerns are discussed sensitively, without blame or judgement, with attention to patient privacy.
Life Fertility Centre is located at Nirmala Maternity & Surgical Hospital, providing access to fertility consultations for patients in South Mumbai and surrounding areas.
MBBS, MS (Obstetrics & Gynaecology), DNB (Obstetrics & Gynaecology)
Fellowship in Reproductive Medicine | Advanced Diploma in Reproductive Medicine, Kiel, Germany
Dr. Katha Desai leads Life Fertility Centre at Nirmala Maternity & Surgical Hospital, South Mumbai.
Her specialised training in reproductive medicine, including advanced education in Germany, supports a comprehensive approach to infertility evaluation and assisted reproductive treatment.
She has contributed to FOGSI clinical manuals and is an active member of the Mumbai Obstetric & Gynaecological Society (MOGS).
Her approach emphasises evaluating both partners, understanding the underlying causes of infertility and recommending treatments according to individual reproductive needs.
For male conditions requiring specialised urological assessment or surgery, coordinated care with an appropriately qualified andrologist or reproductive urologist may be necessary.
The cost of male infertility evaluation and treatment in Mumbai varies depending on the investigations required, underlying diagnosis and treatment approach.
Broad private-sector planning estimates, not verified Life Fertility Centre prices. Actual charges vary by provider, testing method and treatment inclusions.
| Investigation or treatment | Indicative cost in Mumbai |
|---|---|
| Basic semen analysis | ₹500–₹1,500 |
| Advanced semen analysis | ₹1,000–₹3,000 |
| Sperm DNA fragmentation test | ₹4,000–₹10,000 |
| Hormonal profile | ₹2,000–₹6,000 |
| Scrotal Doppler ultrasound | ₹1,500–₹3,500 |
| IVF with ICSI | ₹1.5–₹3 lakh or more |
| Surgical sperm retrieval | Varies substantially by technique and facility |
Patients should request an itemised quotation before beginning treatment.
For an accurate semen analysis test cost in Mumbai or a personalised treatment estimate, consult Life Fertility Centre.
Male infertility is common, and a detailed fertility evaluation can help identify possible causes and suitable treatment options.
At Life Fertility Centre, Dr. Katha Desai offers confidential, personalised fertility consultations and evidence-based guidance to help couples make informed decisions.
Life Fertility Centre
Nirmala Maternity & Surgical Hospital, South Mumbai